ARCHERDX, INC.

Profile

Company Names

ARCHERDX, INC.

Addresses

2477 55TH STREET, SUITE 202, BOULDER, CO 80301

Phone Numbers

8777711093

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$115,131,759.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2020-04-27 
$1,558,465.00 
$1,558,465.00 
$0.00 
 
5
2020-02-26 
$1,300,000.00 
$1,300,000.00 
$0.00 
 
4
2019-12-17 
$4,631,250.00 
$4,631,250.00 
$0.00 
 
3
2019-12-11 
$54,999,913.00 
$54,999,999.00 
$86.00 
Equity 
2
2019-05-10 
$14,999,989.00 
$18,116,924.00 
$3,116,935.00 
Equity 
1
2018-03-05 
$37,642,142.00 
$37,642,142.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARVIN 
 
CARUTHERS 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  ARCHERDX, INC.
MARVIN 
H. 
CARUTHERS 
DIRECTOR
ARRAY BIOPHARMA INC   |  ARCHERDX, INC.
BENJAMIN 
 
CARVER 
EXECUTIVE OFFICER
ARCHERDX, INC.
TODD 
 
DRULEY 
EXECUTIVE OFFICER
ARCHERDX, INC.   |  PAIRIDEX INC.
STEVEN 
 
KAFKA 
DIRECTOR
ARCHERDX, INC.   |  THIRD ROCK VENTURES V, L.P.
STEVEN 
J. 
KAFKA 
DIRECTOR
ARCHERDX, INC.   |  MANIFOLD BIOTECHNOLOGIES, INC.
CHRISTIAN 
 
LAPOINTE 
EXECUTIVE OFFICER
ARCHERDX, INC.
KYLE 
 
LEFKOFF 
DIRECTOR
HIBERNA CORP   |  CENTERSTONE TECHNOLOGIES INC   |  MIRAGEN THERAPEUTICS INC   |  BIOPTIX DIAGNOSTICS, INC.   |  LINERATE SYSTEMS, INC.   |  MARKET FORCE INFORMATION INC   |  PROFOLDRX, INC.   |  BAROFOLD, INC.   |  COMMERCIALTRIBE INC.   |  MIRAGEN THERAPEUTICS, INC.   |  BLACK BEAR ENERGY, INC.   |  ARCHERDX, INC.   |  BOULDER VENTURES VIII, L.P.   |  BOULDER VENTURES VIII (ANNEX), L.P.   |  AMBROSIA BIOSCIENCES INC.
KYLE 
A. 
LEFKOFF 
DIRECTOR
ARRAY BIOPHARMA INC   |  MIRAGEN THERAPEUTICS, INC.   |  ARCHERDX, INC.
PAUL 
 
MANNING 
DIRECTOR
GEN9, INC.   |  ENZYMATICS INC   |  AVEXIS, INC.   |  VERRICA PHARMACEUTICALS INC.   |  ARCHERDX, INC.   |  ADVANTAGENE, INC.   |  TOLERION, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
PAUL 
B. 
MANNING 
DIRECTOR
DOVA PHARMACEUTICALS, INC.   |  XALUD THERAPEUTICS, INC.   |  ARCHERDX, INC.   |  TAYSHA GENE THERAPIES, INC.   |  LIQUIDIA CORP   |  VERRICA PHARMACEUTICALS INC.
MARK 
 
MASSARO 
EXECUTIVE OFFICER
ARCHERDX, INC.   |  JORVA PARTNERS B, LP   |  JORVA PARTNERS A, LP
JASON 
 
MYERS 
EXECUTIVE OFFICER, DIRECTOR
JOBSITE123.COM, LLC   |  DSCS LLC   |  ARCHERDX, INC.   |  GENAPSYS, INC.   |  TWINSTRAND BIOSCIENCES, INC.   |  SWITCHBACK SYSTEMS, INC.
JASON 
W. 
MYERS 
EXECUTIVE OFFICER, DIRECTOR
ARCHERDX, INC.
BRITTON 
A. 
RUSSELL 
EXECUTIVE OFFICER
ARCHERDX, INC.
JASON 
C. 
RYAN 
DIRECTOR
ARCHERDX, INC.
JOSHUA 
 
STAHL 
EXECUTIVE OFFICER
ARCHERDX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-30
D
Link
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
 
2020-04-27 
2020-03-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2019-12-17 
2020-03-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2020-02-26 
2019-12-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-11 
2019-05-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-10 
2018-03-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
EVERCORE GROUP L.L.C.
42405